These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37722207)

  • 21. [The detection of Pasteurella multocida toxin using a commercially available ELISA].
    Weber A; Wachowitz R; Singer H; Heil-Franke G
    Berl Munch Tierarztl Wochenschr; 1993 Oct; 106(10):328-30. PubMed ID: 8250823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin.
    Bording A; Foged NT
    Vet Microbiol; 1991 Nov; 29(3-4):267-80. PubMed ID: 1771750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection by in-situ hybridization of Pasteurella multocida toxin (toxA) gene in the lungs of naturally infected pigs.
    Ahn KK; Lee YH; Ha Y; Kim D; Chae S; Kim CH; Lee JH; Kim SH; Chae C
    J Comp Pathol; 2008 Jul; 139(1):51-3. PubMed ID: 18495148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin.
    Babb RC; Homer KA; Robbins J; Lax AJ
    PLoS One; 2012; 7(11):e47188. PubMed ID: 23144805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
    Seo J; Pyo H; Lee S; Lee J; Kim T
    Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.
    Chakraborty S; Kloos B; Roetz N; Schmidt S; Eigenbrod T; Kamitani S; Kubatzky KF
    Immunobiology; 2018 Jan; 223(1):142-150. PubMed ID: 29030011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
    Kim T; Son C; Lee J; Kim K
    Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.
    Lee J; Kang HE; Woo HJ
    Clin Vaccine Immunol; 2012 Sep; 19(9):1526-31. PubMed ID: 22837096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation.
    Lax AJ; Grigoriadis AE
    Int J Med Microbiol; 2001 Sep; 291(4):261-8. PubMed ID: 11680786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A minimal medium for growth of Pasteurella multocida.
    Jablonski PE; Jaworski M; Hovde CJ
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):165-9. PubMed ID: 8764479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pasteurella multocida toxin interaction with host cells: entry and cellular effects.
    Wilson BA; Ho M
    Curr Top Microbiol Immunol; 2012; 361():93-111. PubMed ID: 22552700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration that Australian Pasteurella multocida isolates from sporadic outbreaks of porcine pneumonia are non-toxigenic (toxA-) and display heterogeneous DNA restriction endonuclease profiles compared with toxigenic isolates from herds with progressive atrophic rhinitis.
    Djordjevic SP; Eamens GJ; Ha H; Walker MJ; Chin JC
    J Med Microbiol; 1998 Aug; 47(8):679-88. PubMed ID: 9877188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental model of swine pneumonic pasteurellosis using crude Actinobacillus pleuropneumoniae cytotoxin and Pasteurella multocida given endobronchially.
    Chung WB; Bäckström LR; Collins MT
    Can J Vet Res; 1994 Jan; 58(1):25-30. PubMed ID: 8143249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pasteurella multocida toxin (PMT) upregulates CTGF which leads to mTORC1 activation in Swiss 3T3 cells.
    Oubrahim H; Wong A; Wilson BA; Chock PB
    Cell Signal; 2013 May; 25(5):1136-48. PubMed ID: 23415771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
    Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
    J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.
    Hildebrand D; Heeg K; Kubatzky KF
    Infect Immun; 2011 Jan; 79(1):220-8. PubMed ID: 20956572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogens of Pasteurella.
    Confer AW
    Vet Microbiol; 1993 Nov; 37(3-4):353-68. PubMed ID: 8116191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.